Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin and CBT in MDD
NCT06746441Phase 2Completed
- Sponsor
- Khyber Medical University
- Start
- Dec 2024
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in major depressive disorder (MDD), sponsored by Khyber Medical University. Started Dec 2024; status: completed.
02
Drugs
psilocybin
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT06746441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06746441.